Trending Stock News

As Colfax (Call) (CFX) Share Price Declined, Shareholder Lodge Hill Capital Trimmed by $22.62 Million Its Holding; Roanoke Asset Management Has Decreased Its Position in Amgen (AMGN) by $341,675

Amgen Inc. (NASDAQ:AMGN) Logo

Roanoke Asset Management Corp decreased its stake in Amgen Inc (AMGN) by 9.2% based on its latest 2017Q4 regulatory filing with the SEC. Roanoke Asset Management Corp sold 1,975 shares as the company’s stock declined 2.99% with the market. The hedge fund held 19,493 shares of the biological products (no diagnostic substances) company at the end of 2017Q4, valued at $3.39M, down from 21,468 at the end of the previous reported quarter. Roanoke Asset Management Corp who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $114.65B market cap company. The stock decreased 0.79% or $1.37 during the last trading session, reaching $171.56. About 2.28 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since April 21, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Clint Murray decreased its stake in Colfax Corp (Call) (CFX) by 74.36% based on its latest 2017Q4 regulatory filing with the SEC. Lodge Hill Capital Llc sold 580,000 shares as the company’s stock declined 20.10% with the market. The hedge fund run by Clint Murray held 200,000 shares of the fluid controls company at the end of 2017Q4, valued at $7.92 million, down from 780,000 at the end of the previous reported quarter. Lodge Hill Capital Llc who had been investing in Colfax Corp (Call) for a number of months, seems to be less bullish one the $4.01 billion market cap company. The stock decreased 0.52% or $0.17 during the last trading session, reaching $32.51. About 424,224 shares traded. Colfax Corporation (NYSE:CFX) has declined 17.80% since April 21, 2017 and is downtrending. It has underperformed by 29.35% the S&P500.

Among 20 analysts covering Colfax (NYSE:CFX), 12 have Buy rating, 3 Sell and 5 Hold. Therefore 60% are positive. Colfax had 66 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, September 25 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. The firm has “Hold” rating given on Wednesday, March 14 by Cowen & Co. The firm has “Overweight” rating by KeyBanc Capital Markets given on Friday, August 25. The rating was maintained by with “Sell” on Monday, October 10. The rating was upgraded by BB&T Capital on Tuesday, May 17 to “Buy”. RBC Capital Markets maintained the shares of CFX in report on Thursday, August 24 with “Buy” rating. The stock has “Buy” rating by Robert W. Baird on Thursday, November 30. As per Friday, July 28, the company rating was maintained by Oppenheimer. RBC Capital Markets maintained the shares of CFX in report on Sunday, February 11 with “Buy” rating. Robert W. Baird maintained the stock with “Buy” rating in Thursday, October 26 report.

Investors sentiment decreased to 0.67 in Q4 2017. Its down 0.39, from 1.06 in 2017Q3. It turned negative, as 53 investors sold CFX shares while 67 reduced holdings. 26 funds opened positions while 54 raised stakes. 93.24 million shares or 2.67% more from 90.81 million shares in 2017Q3 were reported. Tudor Corporation Et Al has 13,903 shares for 0.01% of their portfolio. Fmr Lc has invested 0.01% in Colfax Corporation (NYSE:CFX). D E Shaw & Com Inc holds 330,467 shares. Canada Pension Plan Board holds 132,110 shares. The Pennsylvania-based Glenmede Com Na has invested 0% in Colfax Corporation (NYSE:CFX). Gradient Invests Ltd Liability Com invested in 0% or 15 shares. American Int Grp Inc has invested 0% in Colfax Corporation (NYSE:CFX). Exane Derivatives holds 0% or 581 shares. Voya Inv Management holds 0% or 23,851 shares in its portfolio. Royal Bancorporation Of Canada stated it has 0% of its portfolio in Colfax Corporation (NYSE:CFX). Comerica National Bank & Trust has invested 0.05% in Colfax Corporation (NYSE:CFX). Marshall Wace Ltd Liability Partnership holds 6,224 shares or 0.01% of its portfolio. Barrow Hanley Mewhinney And Strauss Limited Company holds 1.52M shares. Prudential Finance stated it has 21,355 shares. Chevy Chase Holdg Inc stated it has 0% in Colfax Corporation (NYSE:CFX).

Analysts await Colfax Corporation (NYSE:CFX) to report earnings on May, 3 before the open. They expect $0.42 EPS, up 20.00% or $0.07 from last year’s $0.35 per share. CFX’s profit will be $51.86M for 19.35 P/E if the $0.42 EPS becomes a reality. After $0.45 actual EPS reported by Colfax Corporation for the previous quarter, Wall Street now forecasts -6.67% negative EPS growth.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 88 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating by Barclays Capital given on Friday, October 13. On Thursday, October 29 the stock rating was maintained by UBS with “Buy”. On Wednesday, June 29 the stock rating was initiated by Bernstein with “Market Perform”. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Neutral” rating by JP Morgan on Wednesday, January 24. On Tuesday, June 13 the stock rating was maintained by Oppenheimer with “Buy”. The firm has “Market Perform” rating given on Thursday, October 26 by BMO Capital Markets. The firm earned “Market Perform” rating on Tuesday, September 1 by Raymond James. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Market Perform” rating by Wells Fargo on Friday, December 4. Gabelli initiated the stock with “Hold” rating in Friday, August 26 report. Atlantic Securities initiated the stock with “Overweight” rating in Friday, December 18 report.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on April, 26 after the close. They expect $3.22 earnings per share, up 2.22% or $0.07 from last year’s $3.15 per share. AMGN’s profit will be $2.15B for 13.32 P/E if the $3.22 EPS becomes a reality. After $2.89 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts 11.42% EPS growth.

Since December 12, 2017, it had 0 buys, and 5 selling transactions for $1.37 million activity.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *